ArticlePharmaceuticals (Basel, Switzerland)2023

Tumor Microenvironment Responsive Nanomicelle with Folic Acid Modification Co-Delivery of Doxorubicin/Shikonin for Triple Negative Breast Cancer Treatment.

Wu Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.